| 10/08/09 |
DATA FEATURING GADOFOSVESET TRISODIUM, THE FIRST AND ONLY MRA
BLOOD POOL AGENT
APPROVED IN THE U.S., PRESENTED AT MRA-CLUB 09:
21ST ANNUAL INTERNATIONAL CONFERENCE ON MAGNETIC RESONANCE ANGIOGRAPHY |
| 9/17/09 |
LANTHEUS MEDICAL IMAGING, INC. INITIATES PHASE 1 STUDY EVALUATING
SAFETY AND DOSIMETRY OF NOVEL HEART FAILURE IMAGING AGENT |
| 8/14/09 |
LANTHEUS CONTINUES TO ADDRESS INDUSTRY SHORTAGE OF Mo-99
RESULTING FROM PROLONGED NRU REACTOR SHUTDOWN |
| 7/09/09 |
LANTHEUS MEDICAL IMAGING, INC. ANNOUNCES FDA AND HEALTH CANADA APPROVAL OF AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (ANSTO)-SUPPLIED KEY MEDICAL ISOTOPE TO MANUFACTURE TECHNELITE® GENERATOR |
| 6/14/09 |
SCIENTISTS WHO MADE SIGNIFICANT CONTRIBUTION TO DISCOVERY OF LANTHEUS MEDICAL IMAGING’S CARDIOLITE® HONORED WITH PRESTIGIOUS NUCLEAR MEDICINE AWARD AT SNM ANNUAL MEETING |
| 6/13/09 |
LANTHEUS MEDICAL IMAGING, INC. TO RECEIVE LEU-DERIVED MO-99 FROM AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (ANSTO) AND BECOMES FIRST TO SUPPLY U.S. MARKET |
| 6/12/09 |
BARI 2D STUDY PRESENTED AT AMERICAN DIABETES ASSOCIATION
SCIENTIFIC SESSIONS UNDERSCORES UTILITY OF SPECT MYOCARDIAL
PERFUSION IMAGING IN IDENTIFYING CARDIOVASCULAR RISK AND
EVALUATING TREATMENT OUTCOMES FOR PATIENTS WITH TYPE 2 DIABETES |
| 6/4/09 |
SPECT MPI WITH CARDIOLITE® USED IN BARI 2D STUDY TO EVALUATE TYPE 2 DIABETES AND CORONARY ARTERY DISEASE TREATMENT STRATEGIES |
| 5/28/09 |
LANTHEUS MEDICAL IMAGING, INC. COMPLETES ENROLLMENT OF CaRES REGISTRY TO FURTHER EVALUATE DEFINITY® IN PATIENTS WITH SUBOPTIMAL ECHOCARDIOGRAMS |
| 5/20/09 |
LANTHEUS MEDICAL IMAGING, INC. TAKES PROACTIVE STEPS TO MITIGATE IMPACT OF GLOBAL MOLYBDENUM-99 SUPPLY CRISIS ON OPERATIONS |
| 4/7/09 |
LANTHEUS MEDICAL IMAGING, INC. ACQUIRES U.S., CANADIAN AND AUSTRALIAN RIGHTS TO MS-325 (formerly marketed as VASOVIST®, gadofosveset trisodium, by Bayer Schering Pharma) FROM EPIX PHARMACEUTICALS |
| 3/30/09 |
LANTHEUS MEDICAL IMAGING PRESENTS PHASE I STUDY RESULTS OF
NOVEL PET MYOCARDIAL PERFUSION IMAGING TRACER AT ACC |
| 3/29/09 |
NEW LANTHEUS STUDY FINDS SIGNIFICANT SURVIVAL BENEFIT FOR
CRITICALLY ILL PATIENTS UNDERGOING CONTRAST-ENHANCED ECHOCARDIOGRAPHY |
| 3/25/09 |
LANTHEUS MEDICAL IMAGING TO PRESENT NEW CARDIAC IMAGING DATA AT THE AMERICAN COLLEGE OF CARDIOLOGY 58th ANNUAL SCIENTIFIC SESSIONS IN ORLANDO |
| 2/24/09 |
NEW STUDY PUBLISHED IN JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY FINDS UTILIZATION OF CONTRAST ECHOCARDIOGRAPHY WITH DEFINITY® IMPROVES PATIENT DIAGNOSIS AND MANAGEMENT |
| 1/27/09 |
NEW STUDY PUBLISHED IN THE JOURNAL OF NUCLEAR CARDIOLOGY EXPLORES THE UTILITY OF SPECT MYOCARDIAL PERFUSION IMAGING WITH CARDIOLITE® IN PATIENTS WITH NEW-ONSET OF HEART FAILURE |
